Citadel Advisors’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,297
Closed -$245K – 14652
2026
Q1
$245K Buy
+6,297
New +$255K ﹤0.01% 10954
2025
Q4
– Sell
-12,038
Closed -$486K – 13837
2025
Q3
$486K Sell
12,038
-5,113
-30% -$197K ﹤0.01% 9210
2025
Q2
$631K Buy
17,151
+2,450
+17% +$83K ﹤0.01% 8085
2025
Q1
$488K Sell
14,701
-2,856
-16% -$99.3K ﹤0.01% 8526
2024
Q4
$608K Buy
+17,557
New +$616K ﹤0.01% 8134
2022
Q4
– Sell
-14,531
Closed -$307K – 15352
2022
Q3
$307K Buy
14,531
+652
+5% +$15.2K ﹤0.01% 9525
2022
Q2
$309K Buy
13,879
+5,386
+63% +$129K ﹤0.01% 9739
2022
Q1
$220K Buy
+8,493
New +$218K ﹤0.01% 11300

Other funds holding RECS

Citadel Advisors's RECS Position: Q2 2026 in Review

Citadel Advisors sold out of Columbia Research Enhanced Core ETF (RECS) in Q2 2026, closing a stake of 6,297 shares — an estimated $245K sold.

Citadel Advisors first reported a position in RECS in Q1 2022 and held it in 8 quarters. The position peaked at $631K in Q2 2025. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Citadel Advisors reported no remaining Columbia Research Enhanced Core ETF position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 6,297 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $245K.
  • Citadel Advisors first reported a position in Columbia Research Enhanced Core ETF in Q1 2022 and held it in 8 quarters.
  • Citadel Advisors's Columbia Research Enhanced Core ETF position peaked at $631K in Q2 2025.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.